Lighthouse Investment Partners’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Lighthouse Investment Partners’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60,000	Closed	-$45K	–	988
2026 Q1	$45K	Hold	60,000	–	–	﹤0.01%	684
2025 Q4	$42.6K	Hold	60,000	–	–	﹤0.01%	856
2025 Q3	$45K	Hold	60,000	–	–	﹤0.01%	595
2025 Q2	$52.5K	Buy	+60,000	New	+$46.3K	﹤0.01%	528

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BGGS

Boussard & Gavaudan Gestion SAS Paris, France $1.99B AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Lighthouse Investment Partners's OACCW Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) in Q2 2026, closing a stake of 60,000 shares — an estimated $45K sold.

Lighthouse Investment Partners first reported a position in OACCW in Q2 2025 and held it in 4 quarters. The position peaked at $52.5K in Q2 2025. 27 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

Lighthouse Investment Partners reported no remaining Oaktree Acquisition Corp III Life Sciences Warrant position as of Q2 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 60,000 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q2 2026, an estimated $45K.
Lighthouse Investment Partners first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q2 2025 and held it in 4 quarters.
Lighthouse Investment Partners's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $52.5K in Q2 2025.
27 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.